Hci Group Inc
Change company Symbol lookup
Select an option...
HCI Hci Group Inc
PSF Cohen & Steers Select Preferred and Income Fund
PJT PJT Partners Inc
ALK Alaska Air Group Inc
RS Reliance Steel & Aluminum Co
HFWA Heritage Financial Corp
MET MetLife Inc
KALU Kaiser Aluminum Corp
STBA S&T Bancorp Inc
VLY Valley National Bancorp
Go

Financials : Insurance | Small Cap Blend
Company profile

HCI Group, Inc. (HCI) is an insurance holding company. The Company operates through four operating divisions: property and casualty insurance, reinsurance, investment real estate and information technology. Its operations include Insurance Operations and Other Operations. Its Insurance Operations include property and casualty insurance, and reinsurance. The Company, through its subsidiary, Homeowners Choice Property & Casualty Insurance Company, Inc. (HCPCI), provides property and casualty insurance to homeowners, condominium owners and tenants on properties located in Florida. HCPCI also offers flood-endorsed and wind-only policies to new and pre-existing Florida customers. Its Other Operations include information technology (IT) and real estate. The Company's real estate operations consist of multiple properties it owns and operates.

Postmarket

Last Trade
Delayed
$0.00
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$50.50
Day's Change
1.67 (3.42%)
Bid
--
Ask
--
B/A Size
--
Day's High
50.65
Day's Low
48.59
Volume
(Average)
Volume:
34,866

10-day average volume:
34,098
34,866

Skin Cancer Treatment Market to Touch USD 14.55 Billion with 7.5 % CAGR by 2027; High Investment in Product R&D to Aid Growth, says Fortune Business Insights(TM)

8:36 am ET September 29, 2020 (Globe Newswire) Print

The global skin cancer treatment market size is projected to reach USD 14.55 billion by the end of 2027. The increasing prevalence of non-melanoma cancer across the world will have a huge impact on market growth.

According to a report published by Fortune Business Insights, titled "Skin Cancer Treatment Market Size, Share & Industry Analysis, By Disease Indication (Melanoma and Non-Melanoma), By Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, and Radiation Therapy), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others), and Regional Forecast, 2020-2027," the market was worth USD 8.19 billion in 2019 and will exhibit a CAGR of 7.5% during the forecast period, 2019-2027.

Highlights of the Report:

-- Analysis of the impact of Covid-19 that the market would face in the near future.

-- In-depth analysis of the growth drivers and obstacles.

-- Profile of all the companies operating in the market.

-- Elaborate data about the dominating region.

-- Competitive landscape consisting of mergers & acquisitions, investments, partnerships, new product launches, opening of new facilities, and new contracts.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/skin-cancer-treatment-market-102806

Skin cancer is a serious form of disorder that normally affects the part of the skin that is exposed to the sun. The severity of the disease has led to an emphasis on early detection and treatment. As a result, there is a huge awareness regarding the ways to prevent the diseases as well as the options available for treatment. Increasing number of regulatory approvals for treatment options associated with the disease will emerge in favor of market growth.

The high prevalence of skin cancer across the world will open up a huge potential for the companies operating in this market. According to the American Academy of Dermatology Association, 1 in every 5 people in the United States suffers from skin cancer. The numerous treatment options associated with the disease, including immunotherapy, targeted therapy, and chemotherapy will favor growth of the skin cancer treatment market in the coming years.

Industry Developments:

February 2019: Pembrolizumab (Keytruda) received approval from the US Food and Drug Administration for the treatment of Merkel Cell Carcinoma.

The whole world is fighting the novel coronavirus. Sectors and industries are devasted due to the major loss caused by COVID-19 in business. The authorities of several countries have initiated lockdown to prevent the spread of this deadly virus. Such plans have caused disturbances in the production and supply chain. But, with time and resolution, we will be able to combat this stern time and get back to normality. Our well-revised reports will help companies to receive in-depth information about the present scenario of every market so that you can adopt the necessary strategies accordingly.

To get to know more about the short-term and long-term impacts of COVID-19 on this market, please visit: https://www.fortunebusinessinsights.com/skin-cancer-treatment-market-102806

Growing Regulatory Approvals Will Aid Growth of the Market

The report encompasses several factors that have contributed to the growth of the skin cancer treatment market in recent years. The high emphasis and subsequently high investment on the development of efficient treatment options associated with the disease will have a huge impact on the growth of the overall market in the coming years.

Among all factors, the increasing number of regulatory approvals has made the highest impact on market growth. In April 2018, Tafinlar+Mekinist announced the approval for a new therapy used in the treatment of BRAF V600-mutant melanoma. The therapy received allocates from several researchers for its exceptional capabilities in the treatment of the disease. It was awarded the breakthrough designation in 2017 and was submitted for priority review in the same year.

US FDA's approval for this therapy will certainly encourage other companies. Increasing number of such regulatory approvals will bode well for the growth of the skin cancer treatment market in the forthcoming years.

Quick Buy - Skin Cancer Treatment Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/102806

North America Dominate the Market; High Prevalence of Skin Cancer has Emerged in Favor of Companies

The report analyzes the ongoing market trends across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Among these regions, the market in North America currently holds the largest skin cancer treatment market share.

The high prevalence of skin cancer in the United States is a major factor that has contributed to the growth of the regional market. The emphasis of major companies on introducing innovative treatment options and drugs will aid the growth of the market in the coming years. The increasing prevalence of non-melanoma skin cancer in several parts of North America will contribute to the growth of the market.

As of 2018, the market in North America was worth USD 3.04 billion and this value is projected to increase further in the coming years. The skin cancer treatment market in Europe also held a considerably high share in recent years, owing to the presence of several large scale companies in numerous countries across this region.

List of companies profiled in the Skin Cancer Treatment Market report:

-- Merck & Co.

-- Bristol-Myers Squibb Company

-- Novartis AG

-- F. Hoffmann-La Roche Ltd

-- Amgen Inc.

-- GlaxoSmithKline plc.

-- Pfizer Inc.

-- Sun Pharmaceutical Industries Ltd.

-- Regeneron Pharmaceuticals, Inc.

-- Other prominent players

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/skin-cancer-treatment-market-102806

Skin Cancer Treatment Market Segmentations:

By Disease Indication

? Melanoma

? Non-melanoma

By Therapy

? Immunotherapy

? Targeted Therapy

? Chemotherapy

? Radiation Therapy

By Distribution Channel

? Hospitals Pharmacy

? Retail Pharmacy

? Others

By Geography

? North America (U.S. and Canada)

? Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

? Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)

? Latin America (Brazil, Mexico, and Rest of Latin America)

? Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/skin-cancer-treatment-market-102806

Have a Look at Related Reports:

Breast Cancer Therapeutics Market Share and Global Trend By Therapy (Targeted Therapy, Hormonal Therapy, Chemotherapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Cancer Type (Hormone Receptor, HER2+), and Geography Forecast till 2026

Non Small Cell Lung Cancer Therapeutics Market Share and Global Trend by Therapy (Targeted Therapy, Immunotherapy, Chemotherapy), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Cancer Type (Adenocarcinoma, Squamous cell carcinoma, Large cell carcinoma), Geography Forecast till 2026

Cosmetic Dentistry Market Share & Industry Analysis, By Product (Dental Systems & Equipment, Dental Implants, Dental Prosthetics, Orthodontics, Teeth Whitening, and Others), By End User (Dental Hospitals & Clinics, Dental Laboratories, and Others), and Regional Forecast, 2019-2026

Dental Prosthetics Market Share & Industry Analysis, By Type (Crowns, Bridges, Abutments, Dentures, and Others), By End User (Dental Hospitals & Clinics, Dental Laboratories, and Others), and Regional Forecast, 2019-2026

Transcatheter Heart Valve Replacement (THVR) Market Share & Industry Analysis, By Product Type (Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral Valve Replacement (TMVR), and Transcatheter Pulmonary Valve Replacement (TPVR)), By End User (Hospitals, and Specialty Clinics& Others), and Regional Forecast, 2019-2026

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights(TM) Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Fortune Business Insights(TM)

LinkedIn | Twitter | Blogs

Press Release: https://www.fortunebusinessinsights.com/press-release/skin-cancer-treatment-market-9938

https://ml.globenewswire.com/media/05408ba1-26b1-4fdd-8f48-1af4df373348/small/fbi-logo-tm-png.png

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.